Passive anti-amyloid β immunotherapy in Alzheimer's disease-opportunities and challenges.
Lancet (London, England)
View this publicationLancet (London, England)
View this publicationCell reports
View this publicationNature communications
View this publicationPLoS pathogens
View this publicationResearch and practice in thrombosis and haemostasis
View this publicationEuropean journal of immunology
View this publicationOphthalmology science
View this publicationScientific reports
View this publicationJournal of leukocyte biology
View this publicationHamostaseologie
View this publication